CAS RN: 20197-55-1
6,8-DICHLORO[1,3]DIOXOLO[4,5-G]QUINAZOLINE
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 20197-55-1
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shanghai
Inquiry
20197-55-1 / 6,8-dichloro-[1,3]dioxolo[4,5-g]quinazoline
Standard CAS: 20197-55-1
Multi CAS: No
Basic Information
copy
CAS
20197-55-1 copy
Multi CAS
No copy
Molecular Formula
C9H4Cl2N2O2 copy
Molecular Weight
243.040000 copy
Exact Mass
241.964983 copy
SMILES
C1OC2=C(O1)C=C3C(=C2)C(=NC(=N3)Cl)Cl copy
InChI
InChI=1S/C9H4Cl2N2O2/c10-8-4-1-6-7(15-3-14-6)2-5(4)12-9(11)13-8/h1-2H,3H2 copy
InChIKey
FDXFQHNKDXERIJ-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
15 copy
Aromatic heavy atom count
10 copy
Fraction Csp3
0.11 copy
H-bond acceptors
4 copy
Molar refractivity
55.68 copy
TPSA
44.24 copy
LogP / Solubility
WLOGP
2.67 copy
MLOGP
2.35 copy
XLogP3
3.3 copy
Consensus LogP
2.77 copy
Log S (ESOL)
-3.52 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.48 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.45 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.31 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy